| BCBS Federal Medical & Drug | 2.01.04 Hyperbaric Oxygen Therapy | 2025-03-01 |
| BCBS Federal Medical & Drug | 2.01.105 Dry Hydrotherapy for chronic pain conditions | 2025-03-01 |
| Wellcare Hawaii Medicaid Clinical | Behavioral Health Treatment Documentation | 2025-03-01 |
| Wellcare Kentucky Medicaid Clinical | Skin and Soft Tissue Substitutes for Chronic | 2025-03-01 |
| Wellcare North Carolina Medicaid Clinical | Air Ambulance | 2025-03-01 |
| Wellcare North Carolina Medicaid Clinical | Attention Deficit Hyperactivity Disorder | 2025-03-01 |
| Aetna | Daratumumab (Darzalex) and Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) | 2025-02-28 |
| Aetna | Esketamine (Spravato) | 2025-02-27 |
| Aetna | Brexanolone (Zulresso) | 2025-02-27 |
| Aetna | Isatuximab-irfc (Sarclisa) | 2025-02-27 |